Kao, Chester
43  results:
Search for persons X
?
1

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 The..:

Alden, Stephanie L. ; Lim, Mir ; Kao, Chester...
Cancer Research Communications.  3 (2023)  7 - p. 1312-1317 , 2023
 
?
2

Evaluation of tumor microenvironment and biomarkers of immu..:

Brown, Landon C ; Zhu, Jason ; Desai, Kunal...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005249 , 2022
 
?
 
?
4

Clinical outcomes in patients with metastatic renal cell ca..:

Brown, Landon C. ; Desai, Kunal ; Wei, Wei...
Journal for ImmunoTherapy of Cancer.  9 (2021)  9 - p. e003281 , 2021
 
?
6

LRP1Bmutations are associated with favorable outcomes to im..:

Brown, Landon C ; Tucker, Matthew D ; Sedhom, Ramy...
Journal for ImmunoTherapy of Cancer.  9 (2021)  3 - p. e001792 , 2021
 
?
12

A Complete Response After Pseudo-progression: Pembrolizumab..:

Kao, Chester ; McNamara, Megan ; Alley, Chris...
Clinical Genitourinary Cancer.  17 (2019)  3 - p. e672-e677 , 2019
 
?
 
?
 
1-15